<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>jmedicalcasereports</PublisherName>
      <JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
      <PISSN>I</PISSN>
      <EISSN>S</EISSN>
      <Volume-Issue>Volume 2; Issue 4</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>(Jul-Aug, 2021)</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>-0001</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
      <ArticleType>Medical Case Reports</ArticleType>
      <ArticleTitle>One Year of Covid-19 Hospital at Croatia: Prevalence Cardio Comorbidities and Predictors of Health Outcomes - A Retrospective Study</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>1</FirstPage>
      <LastPage>11</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Hrvoje</FirstName>
          <LastName>Jakic</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Hrvoje</FirstName>
          <LastName>Simic</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract>Backround: During the pandemic 2020 many hospitals became so-called Covid-19 Hospital. In Croatia our General County Hospital Nasice was the very first one with declared Covid-19 status. Our objective was to determine the clinical features of patients with severe COVID-19 disease considering of different cardiovascular risk factors and their health outcomes.&#13;
&#13;
Materials and Methods: A retrospective study was conducted by analysing the medical records of 541 hospitalized COVID-19 patients in Croatian General County Hospital Nasice during one year in the period from March 1st 2020 to March 1st 2021. We examined collected individual data as gender, age, presence or absence of comorbidity, type of comorbidity, laboratory data, number of days at hospital and outcomes (discharge home, transfer to another hospital and death).&#13;
&#13;
Results: Patients mean age was 72 years with range of 22 do 95 years. There were 408 (77%) discharged from the hospital, 23 (4%) transferred to another hospital, and 94 (18%) died. Hypertension had 325 (61%) of patients, coronary heart disease had 58 (11%) patients, cardiomyopathy had 98 (19%), arrhythmic disease had 88 (17%), valve disease had 24 (5%). Diabetes as risk factor had 151 patients (29%). Patients without any comorbidity were only 55 (10%). Total range of hospitalized days was 33 with 8 days mean. We found statistically significant differences in disease outcomes according to the gender and age of patients and whether patients suffer from cardiomyopathy and arrhythmic diseases. Age over 65, cardiomyopathy and valve disease were independent predictors of poor outcome for male. For female risk factors were cardiomyopathy, obesity and body mass index.&#13;
&#13;
Conclusions: The prevalence of cardio comorbidity in Croatian Covid-19 hospitalized patients was analyzed and gender-different predictors of health have been identified.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>COVID-19 Disease,Comorbidity,Coronary Disease,Hypertension,Heart Disease Risk Factors</Keywords>
      <URLs>
        <Abstract>https://jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=13104&amp;title=One Year of Covid-19 Hospital at Croatia: Prevalence Cardio Comorbidities and Predictors of Health Outcomes - A Retrospective Study</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>Alemu Y. Predictors Associated with COVID-19 Deaths in Ethiopia. Risk management and healthcare policy 2020; 13: 2769.&#13;
&#13;
Azevedo RB, Botelho BG, de Hollanda JV, Ferreira LV, de Andrade LZ, Oei SS, de Souza Mello T, Muxfeldt ES. Covid-19 and the cardiovascular system: a comprehensive review. Journal of human hypertension 2021; 35: 4-11.&#13;
&#13;
Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD. Heart disease and stroke statistics—2018 update: a report from the American Heart Association. Circulation 2018; 137: e67-492.&#13;
&#13;
Berenguer J, Ryan P, Rodrand;iacute;guez-Baand;ntilde;o J, Jarrand;iacute;n I, Carrataland;agrave; J, Pachand;oacute;n J, Yllescas M, Arriba JR, Muand;ntilde;oz EA, Divasson PG, Muand;ntilde;iz PG. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clinical Microbiology and Infection 2020; 26: 1525-1536.&#13;
&#13;
Birkmeyer JD, Barnato A, Birkmeyer N, Bessler R, Skinner J. The Impact Of The COVID-19 Pandemic On Hospital Admissions In The United States: Study examines trends in US hospital admissions during the COVID-19 pandemic. Health Affairs 2020; 39: 2010-2017.&#13;
&#13;
Bonow RO, O’Gara PT, Yancy CW. Cardiology and COVID-19. JAMA 2020; 324: 1131-1132.&#13;
&#13;
Cen Y, Chen X, Shen Y, Zhang XH, Lei Y, Xu C, Jiang WR, Xu HT, Chen Y, Zhu J, Zhang LL. Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study. Clinical Microbiology and Infection 2020; 26: 1242-1247.&#13;
&#13;
Christensen DM, Strange JE, Gislason G, Torp-Pedersen C, Gerds T, Fosband;oslash;l E, Phelps M. Charlson comorbidity index score and risk of severe outcome and death in Danish COVID-19 patients. Journal of General Internal Medicine 2020; 35: 2801-2803.&#13;
&#13;
Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, Aaron JG, Claassen J, Rabbani LE, Hastie J, Hochman BR. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. The Lancet 2020; 395: 1763-1770.&#13;
&#13;
Dalmazzo LF, de Almendra Freitas AF, Alves BE, Cardoso DK, de Carvalho EF, Akil F, da Cunha Vieira Perini F, Pires KT, de Aguiar LC, Moraes MC, Madeira MI. Transfusion profile, clinical characteristics, comorbidities and outcomes of 3014 hospitalized patients diagnosed with COVID?19 in Brazil. Vox Sanguinis 2021.&#13;
&#13;
Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M, Guo GY, Du J, Zheng CL, Zhu Q, Hu M. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. European Respiratory Journal 2020; 55(5).&#13;
&#13;
Elezkurtaj S, Greuel S, Ihlow J, Michaelis EG, Bischoff P, Kunze CA, Sinn BV, Gerhold M, Hauptmann K, Ingold-Heppner B, Miller F. Causes of death and comorbidities in hospitalized patients with COVID-19. Scientific Reports 2021; 11: 1-9.&#13;
&#13;
Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Archives of Academic Emergency Medicine 2020; 8(1).&#13;
&#13;
Europian Society C Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic, https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance&#13;
&#13;
Galvand;aacute;n-Tejada CE, Zanella-Calzada LA, Villagrana-Baand;ntilde;uelos KE, Moreno-Band;aacute;ez A, Luna-Garcand;iacute;a H, Celaya-Padilla JM, Galvand;aacute;n-Tejada JI, Gamboa-Rosales H. Demographic and comorbidities data description of population in mexico with SARS-CoV-2 infected patients (COVID19): An online tool analysis. International Journal of Environmental Research and Public Health 2020; 17: 5173.&#13;
&#13;
Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biology of sex differences 2020; 11: 1-3.&#13;
&#13;
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA cardiology 2020; 5: 811-818.&#13;
&#13;
Gupta R, Agrawal R, Bukhari Z, Jabbar A, Wang D, Diks J, Alshal M, Emechebe DY, Brunicardi FC, Lazar JM, Chamberlain R. Higher comorbidities and early death in hospitalized African-American patients with Covid-19. BMC Infectious Diseases 2021; 21: 1.&#13;
&#13;
Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, Madhur MS, Tomaszewski M, Maffia P, D’acquisto F, Nicklin SA. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovascular research 2020; 116: 1666-1687.&#13;
&#13;
Jordan RE, Adab P, Cheng K. Covid-19: Risk factors for severe disease and death. British Medical Journal Publishing Group 2020.&#13;
&#13;
Koya SF, Ebrahim SH, Bhat LD, Vijayan B, Khan S, Jose SD, Pilakkadavath Z, Rajeev P, Azariah JL. COVID-19 and Comorbidities: Audit of 2,000 COVID-19 Deaths in India. Journal of Epidemiology and Global Health 2021; 11: 230-232.&#13;
&#13;
Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, Khare S, Srivastava A. Clinical features of COVID-19 and factors associated with severe clinical course: a systematic review and meta-analysis. Social Science Research Network 2020.&#13;
&#13;
Lang JP, Wang X, Moura FA, Siddiqi HK, Morrow DA, Bohula EA. A current review of COVID-19 for the cardiovascular specialist. American heart journal 2020; 226: 29-44.&#13;
&#13;
Liu PP, Blet A, Smyth D, Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation 2020; 142: 68-78.&#13;
&#13;
Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. The American journal of emergency medicine 2020; 38: 1504-1507.&#13;
&#13;
Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. J Med Virol 2020; 92: 401-402&#13;
&#13;
Petrilli CM, Jones SA, Yang J, Rajagopalan H, O’Donnell L, Chernyak Y, Tobin KA, Cerfolio RJ, Francois F, Horwitz LI. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 2020; 369.&#13;
&#13;
Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA 2020; 323: 709-710.&#13;
&#13;
Phelps M, Christensen DM, Gerds T, Fosband;oslash;l E, Torp-Pedersen C, Schou M, Kand;oslash;ber L, Kragholm K, Andersson C, Biering-Sand;oslash;rensen T, Christensen HC. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death. European Heart Journal-Quality of Care and Clinical Outcomes 2021; 7: 172-180.&#13;
&#13;
Puand;scaron;karic F, Cikeand;scaron; M. COVID-19 i bolesnici sa zatajivanjem srca. Medicus 2020; 29(2 COVID-19): 205-210.&#13;
&#13;
Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive care medicine 2020; 46: 846-848.&#13;
&#13;
Strozzi M, Brida M, Doand;scaron;en D, Lovri D, Ani D, Ivanac Vraneand;scaron;ic I, Mari Beand;scaron;ic K, Planinc M, Me?imurec G, Hrabak Paar M. Izvjeand;scaron;taj sa sastanka multidisciplinarnog tima za priroene srane bolesti odraslih odr┼żanog u vrijeme pandemije COVID-a 19. Cardiologia Croatica 2020;15: 296-305.&#13;
&#13;
Sun K, Chen J, Viboud C. Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study. The Lancet Digital Health 2020; 2: e201-e208.&#13;
&#13;
Veer M, Kumar AM, Ivanova V. COVID-19 and the Cardiovascular System. Critical Care Nursing Quarterly 2020; 43: 381-389.&#13;
&#13;
Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L. Heart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation 2020; 141: e139-596.&#13;
&#13;
Wang L, He W, Yu X, Hu D, Bao M, Liu H, Zhou J, Jiang H. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. Journal of Infection 2020; 80: 639-645.&#13;
&#13;
Williamson E, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P, Cockburn J. OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. MedRxiv 2020.&#13;
&#13;
World Health Organisation; https://covid19.who.int/ on 11/04/2021&#13;
&#13;
Wu J, Mafham M, Mamas MA, Rashid M, Kontopantelis E, Deanfield JE, de Belder MA, Gale CP. Place and underlying cause of death during the COVID-19 pandemic: retrospective cohort study of 3.5 million deaths in England and Wales, 2014 to 2020. In Mayo Clinic Proceedings 2021; 96: 952-963.&#13;
&#13;
Yang HJ, Zhang YM, Yang M, Huang X. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2. European Respiratory Journal 2020; 56.&#13;
&#13;
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, Wang Y, Zhou Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International Journal of Infectious Diseases 2020; 94: 91-95.&#13;
&#13;
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nature Reviews Cardiology 2020; 17: 259-260.&#13;
&#13;
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet 2020; 395: 1054-1062.</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>